Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53

United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$460.49K

$460.49K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$460.49K

$0.00 against sales at will